Politiparty
Politiparty
LeaderboardCongressBills

118th Congress Health

H.R. 3008: Drug Shortage Prevention Act of 2023

Introduced

  1. Introduced (completed)Apr 28, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Apr 28, 2023

This bill requires drug manufacturers to notify the Food and Drug Administration (FDA) if there is an increased demand for certain critical essential medicines that may result in a shortage.

Currently, drug manufacturers are required to notify the FDA in the event of a discontinuation or interruption in the supply of prescription drugs that are life-supporting, life-sustaining, or used for a debilitating disease or condition, including those used in medical emergencies, surgeries, or public health emergencies.

The bill requires drug manufacturers to also notify the FDA if there is an increased demand for such drugs that lasts for at least six weeks and that may result in a shortage. Manufacturers must initially notify the FDA of the increased demand within 48 hours after this six-week period and must submit an additional notice within 30 days of the initial notification. The notice must include the reasons for the increased demand, the expected duration, and any other information the FDA requires. The bill's requirements apply to both prescription and nonprescription drugs.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

49

Bipartisan support.

Who scored on this bill

12 points earned
  1. 1Sara Jacobs D-CA SponsorDrew cross-party cosponsors, reached a cosponsor milestone, introduced3 events+12
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Sara Jacobs

History

  1. Apr 28, 2023Introduced in the House by Sara Jacobs.
Show the full action history (3 actions)
  1. May 5, 2023Referred to the Subcommittee on Health.
  2. Apr 28, 2023Introduced in House
  3. Apr 28, 2023Referred to the House Committee on Energy and Commerce.